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Objective: This study was undertaken to investigate the effects of substituting multi-station total outflow contrast
medium–enhanced magnetic resonance angiography (CE-MRA) for color duplex ultrasound (US) scanning on treatment
planning in the diagnostic workup of patients with suspected or known peripheral arterial occlusive disease.
Patients and Methods: One hundred consecutive patients referred because of suspected or proved peripheral arterial
occlusive disease to a University Hospital underwent both aortoiliac duplex US scanning and multi-station total outflow
CE-MRA. For 73 of these patients (57% men; mean age, 62 years) treatment or treatment plans could be retraced.
Eighteen patients also underwent femoro-popliteal duplex US scanning. Three experienced vascular surgeons retrospec-
tively formulated two sets of treatment plans based on standardized clinical parameters and either duplex US scanning or
CE-MRA. The main outcome measure was proportion of patients for whom the treatment plan matched actual treatment
without additional use of intra-arterial digital subtraction angiography. Actual treatment, based on all available
information, including results of duplex US scanning, CE-MRA, and any other diagnostic tests, served as the standard of
reference.
Results: Duplex US scanning provided enough information for treatment planning in 46, 45, and 53 patients versus 67,
68, and 66 patients when CE-MRA was used (surgeons 1, 2, and 3, respectively; surgeons 1 and 2, P < .001; surgeon 3,
P  .007). Treatment plans based on duplex US scanning exactly matched actual treatment in 37 of 73 patients (51%;
surgeon 1), 36 of 73 patients (49%; surgeon 2), and 46 of 73 patients (63%; surgeon 3). Treatment plans based on
CE-MRA exactly matched actual treatment in 56 of 73 patients (77%; surgeon 1), 55 of 73 patients (75%; surgeon 2), and
51 of 73 patients (70%; surgeon 3). Positive predictive value and negative predictive value of duplex US scanning as
measures of ability to discriminate between surgical and nonsurgical treatment were 0 of 0 (undefined) and 43 of 46
(93%), 1 of 2 (50%) and 40 of 43 (93%), and 5 of 5 (100%) and 44 of 48 (92%) for surgeons 1, 2, and 3, respectively. For
CE-MRA, positive and negative predictive values were 11 of 13 (85%) and 50 of 54 (93%), 10 of 12 (83%) and 51 of 56
(91%), and 8 of 13 (62%) and 48 of 53 (91%), respectively, for surgeons 1, 2, and 3.
Conclusion: Compared with aorto-iliac and femoro-popliteal duplex US scanning, multi-station total outflow CE-MRA
is more effective for treatment planning in most patients with known or suspected peripheral arterial occlusive disease. (J
Vasc Surg 2003;37:1255-62.)
Peripheral arterial occlusive disease is a significant
source of morbidity in western society, with an estimated
incidence of 2 to 10 new cases per 1000 persons per year.1
At presentation, patients with peripheral arterial occlusive
disease usually complain of intermittent claudication, and
the diagnosis of peripheral arterial occlusive disease can be
made on the basis of the typical history and findings at
physical examination.2-4
First-line treatment consists of institution of exercise
training and modification of cardiovascular risk factors such
as smoking and hyperlipidemia. When a patient experiences
too much impairment in daily routine despite these mea-
sures, percutaneous or surgical intervention is usually con-
sidered. Before intervention, precise mapping of the site
and extent of peripheral arterial occlusive disease is neces-
sary. For this purpose, duplex ultrasound (US) scanning is
routinely used in many centers and enables reasonably
accurate detection of the presence of stenoses and occlu-
sions in the aorto-iliac and femoro-popliteal arteries and in
arterial bypass grafts.5 Disadvantages of duplex US scan-
ning include that it is operator- dependent and time-con-
suming, and obese patients or patients with excessive bowel
gas or calcified arteries are difficult to examine.6 These
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limitations are the main reason why a substantial number of
patients still must undergo diagnostic intra-arterial digital
subtraction angiography (IA-DSA) before the exact extent
and severity of peripheral arterial occlusive disease is known
and lesions amenable to therapy can be identified. Al-
though a reasonably safe procedure, diagnostic IA-DSA
demands intra-arterial catheterization, hospitalization for
at least several hours, exposure to x-rays, and administra-
tion of nephrotoxic iodinated contrast medium.
Recently, contrast medium-enhanced magnetic reso-
nance angiography (CE-MRA) has evolved as an alternative
method for depicting the peripheral arterial tree.7 With
CE-MRA, images similar to those of IA-DSA can be ob-
tained from the infrarenal aorta to the ankles.8,9 Despite
this, the utility of CE-MRA as a tool for interventional
planning has not been investigated extensively, and specif-
ically not in comparison with duplex US scanning.
The purpose of this study was to investigate the effect
of substituting total outflow CE-MRA for duplex US scan-
ning on treatment planning in the diagnostic workup of
patients with suspected or known peripheral arterial occlu-
sive disease. The central question was which imaging
method, duplex US scanning or CE-MRA, could better
enable prediction of actual treatment without additional
use of IA-DSA. To answer this question, retrospectively
formulated treatment plans based on either duplex US
scanning or CE-MRA were compared with the actual treat-
ment, which was based on all available diagnostic informa-
tion from duplex US scanning, CE-MRA, and any addi-
tional diagnostic procedures. In addition, we evaluated
ability of duplex US scanning and CE-MRA to enable
differentiation of patients with and without an indication
for surgery.
PATIENTS AND METHODS
Patients and diagnostic workup algorithm. Over
17 months between September 1999 and January 2001,
100 consecutive patients referred by their vascular surgeons
for duplex US scanning because of known or suspected
peripheral arterial occlusive disease also underwent CE-
MRA of the peripheral arterial tree. Because retrospectively
formulated treatment plans were compared with actual
treatment, patients were only enrolled in the current study
if the intended or actual treatment, based on all available
information from duplex US scanning, CE-MRA, and any
other tests, could clearly be established from patient
records. This was the case for 73 of 100 patients, including
29 women and 44 men with a mean (ÅSD) age of 62 Å 10.0
years (range, 41-81 years), with 117 symptomatic extrem-
ities. Other patient characteristics are listed in Table I.
Before duplex US scanning and CE-MRA, all patients
underwent resting and post-exercise ankle brachial index
(ABI) measurements. Post-exercise ABI was measured after
a standardized walking test on a treadmill, lasting a maxi-
mum of 5 minutes. Currently, duplex US scanning is the
standard imaging method used at our hospital for diagnos-
tic workup of peripheral arterial occlusive disease, and
CE-MRA is considered an investigative procedure. The
study design and diagnostic workup algorithm for patients
with intermittent claudication, as used in our hospital, is
shown in the Figure 1. Patients were not included in the
study if they were claustrophobic (n  2) or had a pace-
maker (n  1) or non-MR-compatible ferromagnetic im-
plant, eg, certain intracranial aneurysm clips or hearing
ossicles (n 0). Mean (ÅSD) delay between CE-MRA and
duplex US scanning was 4.9 Å 4.2 days (range, 13 days
before to 21 days after) and was subject to availability of the
MR scanner. The institutional review board approved the
study protocol, and all patients signed informed consent
before inclusion in the study.
Duplex US scanning. On the basis of history and
findings at physical examination, the referring vascular sur-
geons determined the extent of duplex US scanning (aorto-
iliac only or including the femoro-popliteal arteries). Du-
plex US scanning was performed by qualified, experienced
vascular technologists, all with more than 5 years of expe-
rience, who were unaware of the findings of the CE-MRA
examination. For duplex US scanning, patients were placed
in the supine position, and the abdominal aorta, common
and external iliac arteries, and common femoral arteries
were insonated with a 5 MHz convex transducer. In the
presence of excessive bowel gas or obesity, a 3.5 MHz
convex transducer was used. When the femoropopliteal
arteries (n  18) were scanned, a 7.5 MHz linear trans-
ducer was used. In every named vessel segment, peak
systolic velocity ratio (PSVR) was measured and recorded
on a standard reporting sheet, indicating the grade of
stenosis on a five-point scale. PSVR was calculated by
dividing velocity measured at the point of maximum steno-
sis by velocity in the closest adjacent normal vessel segment.
The cutoff points for aorto-iliac duplex US scanning were
PSVR less than or equal to 1.5 for 0% to 19% stenosis;
PSVR less than 2.5 for 20% to 49% stenosis; PSVR 2.5 or









Patients seen for the first time 42
Previous percutaneous intervention 19
Previous surgical intervention 12
Smoker 46




Carotid artery disease 9
Kidney transplantation 0
Pulmonary disease 7
Resting ankle-brachial index (mean  SD) 0.66  0.25
Post-exercise ankle-brachial index (mean SD) 0.48  0.29
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greater for 50% to 74% stenosis; PSVR greater than 2.5 and
end-diastolic velocity more than 60 cm/s for 75% to 99%
stenosis; and no Doppler signal for occlusion. For the
femoro-popliteal arteries the cutoff points were PSVR less
than 2.5 for 0% to 50% stenosis; PSVR 2.5 or greater for
50% to 99% stenosis; and no Doppler signal for occlusion.
All duplex US scanning was performed with Aloka (Tokyo,
Japan) 2000 or 5500 color-aided duplex US scanning
devices. Total patient handling time for aorto-iliac duplex
US scanning was about 45 to 60 minutes, and including the
femoro-politeal arteries was about 60 to 90 minutes.
MRA. All MR images were acquired with a 1.5 T MR
scanner (Gyroscan Intera; Philips Medical Systems, Best,
The Netherlands) with commercially available pulse se-
quences. To depict the arteries of the lower limb, a stepping
table approach was used. With this scanning technique
high-resolution three-dimensional (3D) images of the ar-
terial system from the abdominal aorta to the ankles can be
obtained by scanning three separate volumes, for the aorto-
iliac, and upper and lower leg arteries, in immediate succes-
sion. The CE-MRA procedure consisted of three steps:
acquisition of localizer scans, acquisition of 3D unen-
hanced “mask” scans, and acquisition of identical 3D scans
during administration of 35 mL of gadolinium-diethyl-
enetetrapentaacetic acid contrast material (Magnevist;
Schering, Berlin, Germany). To increase vessel-to-back-
Fig 1. Study design. PAOD, Peripheral arterial occlusive disease; CE-MRA, contrast-enhanced magnetic resonance
angiography; DU, color-aided duplex ultrasound scanning.
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ground contrast, mask scans were subtracted from the
corresponding CE-MRA scans after acquisition. The full
technical details and parameter settings of the CE-MRA
scanning procedure have been described.10 After image
acquisition, CE-MRA images were transferred to a dedi-
cated post-processing workstation (EasyVision, rel 4.2;
Philips Medical Systems), where they were read by the
attending radiologist experienced in reading CE-MRA
datasets. For every named vessel segment, from the infra-
renal aorta to the ankles, the presence of stenoses and
obstructions were recorded. Stenoses were classified on the
same five-point scale as used for duplex US scanning and
were calculated by dividing the luminal diameter at maxi-
mum stenosis by the luminal diameter of the closest adja-
cent normal vessel diameter. In every vessel segment, only
the most severe stenosis was recorded. In addition to
information about grade of stenoses, as determined by the
radiologist, coronal and sagittal maximum intensity projec-
tion images of all three stations were printed on film and
made available for the vascular surgeons formulating the
treatment plans. Total patient handling time for CE-MRA
was about 20 minutes. For post-processing and interpreta-
tion of data, an additional 15 to 20 minutes was needed.
Further diagnostic and treatment plans. Three se-
nior vascular surgeons with multiple years of experience in
interpreting both duplex US scans and CE-MRA images
formulated two sets of treatment plans for all patients 3
months after the last patient was included. Treatment plans
were formulated based on standardized clinical information
and the results of either duplex US scanning or CE-MRA.
The two sets of treatment plans each vascular surgeon made
were compared with the actual treatment the patients re-
ceived. Standardized clinical information consisted of pa-
tient age and sex; number, location, and nature of previous
vascular interventions, eg, angioplasty, stenting, surgeries;
pain-free walking distance more or less than 100 m; pres-
ence or absence of rest pain or tissue loss; location of
complaints, ie, left or right side or both); duration of
complaints, ie, less than 3 months, 3 months to 1 year, and
more than 1 year; patient risk profile, ie, smoking, hyper-
tension, diabetes, hypercholesterolemia, cardiac, renal, pul-
monary, and neurologic history, according to Rutherford
et al11); and resting and post-exercise ABI measurements
for both lower extremities. After receiving this standardized
information the vascular surgeon was given the results of
either duplex US scanning or CE-MRA. The first decision
that had to be made was whether any further diagnostic
procedure, eg, diagnostic IA-DSA, was needed or whether
the available information was sufficient to formulate a treat-
ment plan. If the vascular surgeon considered the informa-
tion sufficient, he was requested to formulate a treatment
plan from the treatment options shown in Table II.
Over 4 months, the 3 vascular surgeons reviewed all 73
cases and formulated two treatment plans, one based on
findings at duplex US scanning and one based on CE-MRA
results, in separate sessions. At least 4 weeks elapsed be-
tween treatment planning for the same patient with each
imaging method. The vascular surgeons were kept unaware
of each others’ decisions and of the decisions they had made
on the basis of the other imaging method.
Statistical analysis. The McNemar test was used to
test for differences in number of requested additional diag-
nostic procedures based on the different imaging methods.
In addition to overall comparisons, a separate analysis was
done in the patient group that had undergone both
femoro-popliteal and aorto-iliac duplex US scanning. In
addition, we evaluated the ability of both duplex US scan-
ning and CE-MRA to enable differentiation between con-
servative treatment and percutaneous transluminal angio-
plasty (PTA) versus surgical treatment by calculating
positive predictive value (PPV) and negative predictive
value (NPV). We did this because, in clinical practice,
noninvasive testing is important to establish whether surgi-
cal intervention is indicated. P  .05 (2-tailed test) was
considered statistically significant.
RESULTS
All 73 patients underwent duplex US scanning and
CE-MRA without any adverse events. In addition to aorto-
iliac duplex US scanning, 18 patients also underwent du-
plex scanning of the femoro-popliteal arteries. In 53 pa-
tients the actual treatment was PTA, and in 16 patients it
was surgery. Four patients had no signs of peripheral arte-
rial occlusive disease on either duplex US scans or CE-MRA
images. Of the patients who underwent superficial femoral
duplex US scanning in addition to aorto-iliac duplex scan-
ning, 10 underwent infrainguinal interventions, including
superficial femoral PTA in 3 patients and femoro-popliteal
bypass grafting in 7 patients. Except for 1 patient, all
patients who underwent infrainguinal surgical interven-
tions had also undergone superficial femoral duplex US
scanning. Six patients had previously implanted vascular
stents, which rendered CE-MRA inconclusive in these pa-
tients except for 1 patient with a nitinol stent, which
rendered that patient’s images evaluable in the opinion of a
single surgeon.
When trying to formulate a treatment plan based on
findings on duplex US scans, the 3 surgeons required
additional information, ie, IA-DSA images, in 37% (27 of
73), 38% (28 of 73), and 27% (20 of 73) of patients,
Table II. Treatment options
0 Conservative treatment, ie, exercise training, modification of
risk factors
1 Percutaneous transluminal angioplasty with or without
primary stenting, in iliac arteries
2 Percutaneous transluminal angioplasty in femoral arteries
3 Aortobifemoral bifurcation graft
4 Unilateral iliac artery bypass
5 Surgical endarterectomy of common femoral artery
6 Femoro-femoral crossover bypass
7 Femoro-popliteal bypass, above-knee distal anastomosis
8 Femoro-popliteal bypass, below-knee distal anastomosis
9 Femoro-tibial bypass
10 Amputation, exact level specified
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respectively (Table III). Additional information from IA-
DSA was needed in significantly lower proportions in treat-
ment planning based on CE-MRA images: 8% (6 of 73), 7%
(5 of 73), and 10% (7 of 73), respectively (surgeons 1 and
2, P  .001; surgeon 3, P  .007). In the patient group
that had undergone both femoro-popliteal and aorto-iliac
duplex US scanning, surgeons 1 and 2 also ordered signif-
icantly fewer additional diagnostic procedures based on
CE-MRA (surgeon 1, P  .001; surgeon 2, P  .04;
surgeon 3, P .22). Thus surgeons were able to formulate
more treatment plans based on CE-MRA images. This
difference was most notable for the surgical treatment
options, which, based on duplex US scans, were chosen in
0%, 4%, and 9% of patients by the respective surgeons.
Based on CE-MRA images, surgery was chosen in 19%,
18%, and 20% of patients, respectively.
The proportion of patients in whom treatment plans
based on duplex US scans or CE-MRA images alone
matched actual treatment is shown in Table III. Correct
prediction of actual treatment without use of additional
information from IA-DSA was achieved in 51% (37 of 73),
49% (36 of 73), and 63% (46 of 73) of patients, respec-
tively, when treatment plans were formulated based on
duplex US scans alone, compared with 77% (56 of 73), 75%
(55 of 73), and 73% (51 of 73), respectively, when treat-
ment plans were formulated based on CE-MRA images
alone.
To examine why correct prediction of actual treatment
occurred more often based on CE-MRA findings, the
fractions predicted correctly were compared within the
subgroups of patients for whom the surgeons believed
duplex US scans and CE-MRA images offered enough
information to formulate a treatment plan. Both methods
performed equally well, with about 80% of treatment plans
matching actual treatment.
PPV and NPV are shown in Table IV for ability of
duplex US scanning and CE-MRA to enable differentiation
between nonsurgical and surgical treatment. In the context
of the current study, PPV refers to the probability that
patients for whom the treatment plan was surgery actually
underwent surgery. Conversely, NPV refers to the proba-
bility that patients for whom the treatment plan was non-
surgical actually received conservative treatment or PTA.
For 1 surgeon, PPV for duplex US scanning could not be
calculated because he never chose a surgical treatment
option. For this surgeon and surgeon 2, CE-MRA pre-
dicted surgery with high PPV. For surgeon 3, who had
more experience with duplex US scanning than the other
surgeons did, PPV of a treatment plan for surgery based on
MRA was lower than for the other 2 surgeons. NPV of
treatment plans for nonsurgical interventions based on
duplex US scans and CE-MRA images were uniformly
high.
DISCUSSION
In this study, treatment plans based on standardized
clinical information and results of either duplex US scan-
ning or total outflow CE-MRA were compared in patients
with symptomatic peripheral arterial occlusive disease re-
ferred to the vascular surgeon. The results of this study
demonstrate that vascular surgeons were less likely to order
diagnostic IA-DSA when CE-MRA was available rather
than duplex US scanning to plan treatment, even when
femoro-popliteal duplex US scanning was done in addition
to aorto-iliac scanning. In addition, the vascular surgeons
in this study were able to formulate more surgical treatment
Table III. Percentage of patients in whom treatment plan (numerator) corresponded with actual treatment
(denominator)*
Surgeon 1 Surgeon 2 Surgeon 3
DU CE-MRA DU CE-MRA DU CE-MRA
Fraction of total predicted
correctly (%)
37/73 (51) 56/73 (77) 36/73 (49) 55/73 (75) 46/73 (63) 51/73 (70)
Further information needed
(IA-DSA)
27† 6 28† 5 20† 7
Conservative treatment 100 (4/4) 100 (4/4) 100 (2/2) 100 (4/4) 100 (3/3) 75 (3/4)
Iliac PTA 88 (29/33) 95 (39/41) 85 (29/34) 93 (39/42) 94 (33/35) 88 (37/42)
Femoral PTA 67 (4/6) 57 (4/7) 80 (4/5) 43 (3/7) 83 (5/6) 71 (5/7)
Aortic bifurcation graft NA 100 (3/3) 100 (1/1) 100 (3/3) 100 (3/3) 67 (2/3)
Unilateral iliac artery bypass NA 100 (1/1) NA 100 (1/1) NA 0 (0/1)
Common femoral endarterectomy NA 50 (1/2) 0 (0/1) 50 (1/2) 100 (1/1) NA
Femoro-femoral crossover bypass NA 50 (1/2) NA 100 (2/2) NA 100 (2/2)
Femoro-popliteal bypass, AK 0 (0/3) 40 (2/5) 0 (0/2) 20 (1/5) 20 (1/5) 40 (2/5)
Femoro-popliteal bypass, BK NA 0 (0/1) NA 0 (0/1) NA 0 (0/1)
Femoro-tibial bypass NA 100 (1/1) NA 100 (1/1) NA 0 (0/1)
Amputation‡ NA NA NA NA NA NA
DU, Duplex ultrasound scanning; CE-MRA, contrast-enhanced magnetic resonance angiography; IA-DSA, intra-arterial digital subtraction angiography;
PTA, percutaneous transluminal angioplasty; AK, distal anastomosis above knee; BK, distal anastomosis below knee; NA, not applicable.
*Actual treatment or intended actual treatment as confirmed from patient records.
†Significantly higher compared with CE-MRA.
‡Exact level of amputation specified.
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plans based on CE-MRA images without ordering addi-
tional diagnostic information.
When CE-MRA was used instead of duplex US scan-
ning, all 3 surgeons arrived at a higher percentage of
treatment plans that were in accord with actual treatment
(Table III). This was mainly because CE-MRA results were
sufficient that diagnostic IA-DSA was not necessary. When
the surgeons did believe duplex US scans offered enough
information on which to formulate a treatment plan, it
performed well in predicting conservative and interven-
tional radiologic treatment. CE-MRA was slightly better in
predicting iliac PTA for 2 surgeons, but duplex US scan-
ning was better in predicting femoral PTA for all surgeons.
For surgeons 1 and 2, duplex scanning did not suffice as the
sole imaging method with which to plan surgical interven-
tion. Although CE-MRA performed better in this respect,
it also did not provide enough information in all cases. The
likely explanation for the better performance of CE-MRA
compared with duplex scanning is that CE-MRA provides
anatomic images from the infrarenal aorta to the ankles,
closely resembling IA-DSA images, and surgeons may be
biased toward such relatively easily readable images. In
clinical practice this means surgeons are more likely to
consider the entire spectrum of treatment options, percu-
taneous as well as surgical, when this kind of information is
available.
Despite many studies that have investigated the diag-
nostic accuracy of CE-MRA compared with IA-DSA, ques-
tions remain regarding the important issue of the utility of
CE-MRA compared with duplex US scanning as a tool for
use in planning vascular interventions. We conducted this
study to investigate the potential of CE-MRA to function
as an alternative to duplex US scanning for diagnosis and
preinterventional treatment planning in patients with com-
plaints of peripheral arterial occlusive disease. The key
clinical question we sought to address was whether duplex
US scanning or CE-MRA is most useful in predicting which
patients are candidates for conservative treatment and PTA
versus those patients that have disease that is too diffuse and
long-segmented and requires surgery. This differentiation
is important in clinical practice because many patients and
surgeons might be interested in invasive treatment only if
angioplasty is possible, but less interested if major recon-
struction is required. The current study shows that with
CE-MRA it was more often feasible to make this differen-
tiation for 2 of the 3 surgeons.
Based on CE-MRA images, all 3 surgeons were able to
formulate more treatment plans for surgery. The high PPV
of plans for surgery based on CE-MRA suggest that CE-
MRA can help in selecting patients who are candidates for
invasive procedures. However, the lower PPV found for the
other surgeon with most experience in reading and acquir-
ing duplex scans (Table IV) illustrates that the experience
one has with duplex scanning is an important factor in
therapeutic decision making. Comparison of PPV between
duplex scanning and CE-MRA is not possible, because the
PPV for these methods are based on different subgroups of
patients. NPV for duplex scanning and CE-MRA was high,
indicating that both tests performed well in excluding
patients from surgery when it was not actually required.
Many vascular surgeons still consider a “road map” of
the lower limb vasculature essential when they plan treat-
ment, a view that is also expressed in the Transatlantic
Intersociety Consensus (TASC) document.1 In contrast, a
substantial learning curve exists for acquisition and inter-
pretation of duplex US scans. A limitation of our study in
this respect is that only selected patients underwent duplex
scanning of both the femoro-popliteal arteries and the
aorto-iliac arteries. Different results might have been found
if all patients had undergone superficial femoral duplex
scanning in addition to aorto-iliac scanning. However, in
the subset of patients who underwent femoro-popliteal
duplex scanning in addition to aorto-iliac scanning, 2 of the
3 vascular surgeons still needed additional information
significantly more often when compared with CE-MRA to
formulate a treatment plan. We believe this difference can
be explained because the accuracy of duplex US scanning
for precise planning of femoro-popliteal bypass grafting, in
which information is also needed on lower leg outflow
arteries, is still a subject of debate.12 The current study
shows that, at present, CE-MRA is only slightly better than
duplex US scanning for accurate prediction of this type of
surgery.
In several other studies investigators compared treat-
ment plans based on IA-DSA with those based on duplex
US scanning or MRA. Mulligan et al13 found that treat-
ment plans formulated based on duplex US scans were
more often in agreement with the findings and subsequent
Table IV. Positive and negative predictive values of DU and CE-MRA for differentiation between nonsurgical or
surgical intervention
Surgeon 1 Surgeon 2 Surgeon 3
DU CE-MRA DU CE-MRA DU CE-MRA
Positive predictive value (%) Undefined (0/0) 85 (11/13) 50 (1/2) 83 (10/12) 100 (5/5) 62 (8/13)
Negative predictive value (%) 93 (43/46) 93 (50/54) 93 (40/43) 91 (51/56) 92 (44/48) 91 (48/53)
Sensitivity (%) 0 (0/3) 73 (11/15) 25 (1/4) 67 (10/15) 56 (5/9) 62 (8/13)
Specificity (%) 100 (43/43) 96 (50/52) 98 (40/41) 96 (51/53) 100 (44/44) 91 (48/53)
DU, Duplex ultrasound scanning; CE-MRA, contrast-enhanced magnetic resonance angiography.
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treatment planning based on IA-DSA than treatment plans
formulated based on MRA in 13 patients undergoing 21
interventions. However, in that study non-contrast-en-
hanced MRA was used, which requires prohibitively long
examination time and includes several sources of artifact,
mainly in the aorto-iliac region. This was corroborated in
the study by Hoch et al,14 who compared treatment plans
also based on non-contrast-enhanced MRA with plans
based on IA-DSA in 40 patients.
Because there were discrepancies with actual treatment
with both duplex US scanning and CE-MRA, the results
indicate that in a limited number of patients neither
method supplies enough information and that a combina-
tion of the two techniques or additional diagnostic proce-
dures, eg, IA-DSA, is needed. Kohler et al,15 who com-
pared treatment plans in 29 patients based on duplex US
scans from the infrarenal aorta to the ankles with treatment
plans based on IA-DSA, also reported discrepancies: a mean
of 76% of treatment plans were in exact agreement, and
serious discrepancies between duplex scanning and IA-
DSA were noted for 5 of 29 patients (17%).
The present study has additional limitations. Because
retrospectively formulated treatment plans were compared
with actual treatment on the basis of all available diagnostic
information, ie, duplex US scans, CE-MRA images, and
any additional data from other diagnostic procedures, re-
sults must be interpreted with caution. In an analysis of
treatment decision, as in the present study, it is difficult to
capture every bit of relevant information in a standardized
way that determines actual treatment. However, because
standardized clinical information was given in identical
fashion for duplex US scanning and CE-MRA, surgeons
probably experienced an equal effect of this simplification
of reality with both methods. Another source of variation in
this experiment, in addition to the different diagnostic tests
under investigation, is variation between different surgeons
when making a treatment plan. It should be mentioned that
not every patient can undergo CE-MRA, because of con-
traindications such as claustrophobia or presence of a pace-
maker or intracerebral ferromagnetic vascular clips. A tech-
nical limitation of CE-MRA is that it is not able to provide
information about stenoses and obstructions in some stents
because of artifacts. In the present study this was the case in
6 of 73 patients. Furthermore, CE-MRA is an evolving
technology that is not standardized at present, and results
may have been different if other CE-MRA techniques had
been used. In addition, in contrast to duplex US scanning,
CE-MRA requires injection of contrast material, which
carries a small but not negligible risk for procedure-related
complications.16 Finally, duplex US scanning and CE-
MRA are fundamentally different imaging studies, with
CE-MRA providing anatomic information and duplex
scanning providing hemodynamic information. When
making a treatment decision, ideally both types of informa-
tion should be available.
What are the implications of this study in clinical prac-
tice? Apart from patient preference and other factors, eg,
comorbidity, that influence consideration of treatment op-
tions, information about the exact length and severity of
stenoses and occlusions is needed. CE-MRA, which is only
minimally invasive, can provide such data in a format and
with accuracy similar to that of IA-DSA8,9 and is therefore
a valuable addition to the diagnostic workup in patients
with peripheral arterial occlusive disease. The morphologic
information that can be derived from the CE-MRA dataset
may also facilitate logistics in the angiography suite, be-
cause before an interventional procedure is started, infor-
mation about catheter and stent sizes and grade and locale
of atherosclerotic lesions is available, which may result in
shorter and more targeted interventional procedures. Be-
cause CE-MRA enabled accurate planning of treatment in a
higher proportion of patients, it would make sense to use
CE-MRA as the first imaging study and to use duplex US
scanning when CE-MRA is nondiagnostic or does not
provide the necessary information, ie, when a borderline
lesion is seen or in the presence of stents and metal clips,
which generate artifacts on CE-MRA images.
In conclusion, CE-MRA is a valuable tool for use in
planning percutaneous as well as surgical treatment, with-
out the need for invasive IA-DSA. The limited time needed
to perform the test and interpret the results, combined with
the ability to provide true 3D information on inflow and
outflow vessels, similar to IA-DSA, makes CE-MRA a
compelling alternative to duplex US scanning in centers
with the necessary equipment and expertise.
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